Cerebral Cortex Advance Access published online on July 6, 2004
Cerebral Cortex, doi:10.1093/cercor/bhh123
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Neuroanatomy, Paul Flechsig Institute of Brain Research, University of Leipzig, Jahnallee 59, 04109 Leipzig, Germany
* To whom correspondence should be addressed. E-mail: lueth{at}medizin.uni-leipzig.de.
In this immunohistochemical study, the age- and stage-dependent accumulation of advanced glycation end-products (AGEs) in Alzheimer's disease (AD) and their relation to the formation of neurofibrillary tangles and neuronal cell death was investigated. For this purpose, the distribution of AGEs in neurons and glia was analyzed in the auditory association area of superior temporal gyrus (Brodmann area 22) of young and old non-demented controls and compared with early- and late-stage AD. A possible co-localization of AGEs with typical hallmarks of AD, such as hyperphosphorylated tau (as a marker for disturbed kinase/phosphatase activity), nNOS (as a marker for nitroxidative stress) and caspase-3 (as a marker of apoptotic cell death), was also investigated. Our results show that the percentage of AGE-positive neurons (and astroglia) increase both with age and, in AD patients, with the progression of the disease (Braak stages). Interestingly, nearly all if those neurons which show diffuse cytosolic AGE immunoreactivity also contain hyperphosphoryated tau, suggesting a link between AGE accumulation and the formation of early neurofibrillary tangles. Many, but not all, neurons show a co-localization of AGEs with other markers of neurodegeneration, such as nNOS and caspase-3.
Article
Age- and Stage-dependent Accumulation of Advanced Glycation End Products in Intracellular Deposits in Normal and Alzheimer's Disease Brains
2 Department of Neuropathology, Institute of Pathology, University of Leipzig, Liebigstrasse 26, 04103 Leipzig, Germany
3 Neuroimmunological Cell Biology Unit, IZKF Leipzig, Inselstrasse 22, 04103 Leipzig, Germany
4 Roche Diagnostics GmbH, 82372 Penzberg, Germany
5 Comparative Genomics Centre, James Cook University, Townsville 4811, Australia
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Pichiule, J. C. Chavez, A. M. Schmidt, and S. J. Vannucci Hypoxia-inducible Factor-1 Mediates Neuronal Expression of the Receptor for Advanced Glycation End Products following Hypoxia/Ischemia J. Biol. Chem., December 14, 2007; 282(50): 36330 - 36340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Hulbert, R. Pamplona, R. Buffenstein, and W. A. Buttemer Life and Death: Metabolic Rate, Membrane Composition, and Life Span of Animals Physiol Rev, October 1, 2007; 87(4): 1175 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Treweek, S. Wee, G. F. Koob, T. J. Dickerson, and K. D. Janda Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease PNAS, July 10, 2007; 104(28): 11580 - 11584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Drachman Aging of the brain, entropy, and Alzheimer disease Neurology, October 24, 2006; 67(8): 1340 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sato, N. Shimogaito, X. Wu, S. Kikuchi, S.-i. Yamagishi, and M. Takeuchi Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer's Disease American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 197 - 208. [Abstract] [PDF]
|
|